Results
|
54981.
|
|
|
54982.
|
|
|
54983.
|
Anti-tumor immune response induced by the fractions derived from OK-432, a streptococcal preparation, by using a monoclonal antibody TS-2 that neutralizes the interferon-gamma-inducing activity of OK-432: comparison between the TS-2-binding and TS-2-unbinding fraction. [electronic resource] by
- Oshikawa, Tetsuya
- Okamoto, Masato
- Ohe, Go
- Furuichi, Sachiko
- Nishikawa, Hidetomo
- Uddin Ahmed, Sharif
- Yoshida, Hideo
- Moriya, Yoichiro
- Matsubara, Shuzo
- Ryoma, Yoshiki
- Saito, Motoo
- Sato, Mitsunobu
Producer: 20040301
In:
International immunopharmacology vol. 3
Availability: No items available.
|
|
54984.
|
|
|
54985.
|
Phase II Study of Adjuvant Immunotherapy with the CSF-470 Vaccine Plus Bacillus Calmette-Guerin Plus Recombinant Human Granulocyte Macrophage-Colony Stimulating Factor vs Medium-Dose Interferon Alpha 2B in Stages IIB, IIC, and III Cutaneous Melanoma Patients: A Single Institution, Randomized Study. [electronic resource] by
- Mordoh, José
- Pampena, María Betina
- Aris, Mariana
- Blanco, Paula Alejandra
- Lombardo, Mónica
- von Euw, Erika María
- Mac Keon, Soledad
- Yépez Crow, Michelle
- Bravo, Alicia Inés
- O'Connor, Juan Manuel
- Orlando, Ana Gabriela
- Ramello, Franco
- Levy, Estrella Mariel
- Barrio, María Marcela
Publication details: Frontiers in immunology 2017
In:
Frontiers in immunology vol. 8
Availability: No items available.
|
|
54986.
|
|
|
54987.
|
|
|
54988.
|
|
|
54989.
|
|
|
54990.
|
|
|
54991.
|
|
|
54992.
|
Prognostic factors for survival and factors associated with long-term remission in patients with advanced melanoma receiving cytokine-based treatments: second analysis of a randomised EORTC Melanoma Group trial comparing interferon-alpha2a (IFNalpha) and interleukin 2 (IL-2) with or without cisplatin. [electronic resource] by
- Keilholz, U
- Martus, P
- Punt, C J A
- Kruit, W
- Mooser, G
- Schadendorf, D
- Liénard, D
- Dummer, R
- Koller, J
- Voit, C
- Eggermont, A M M
Producer: 20020913
In:
European journal of cancer (Oxford, England : 1990) vol. 38
Availability: No items available.
|
|
54993.
|
|
|
54994.
|
Immunizing and curative potential of replicating and nonreplicating murine mammary adenocarcinoma cells engineered with interleukin (IL)-2, IL-4, IL-6, IL-7, IL-10, tumor necrosis factor alpha, granulocyte-macrophage colony-stimulating factor, and gamma-interferon gene or admixed with conventional adjuvants. [electronic resource] by
- Allione, A
- Consalvo, M
- Nanni, P
- Lollini, P L
- Cavallo, F
- Giovarelli, M
- Forni, M
- Gulino, A
- Colombo, M P
- Dellabona, P
Producer: 19941227
In:
Cancer research vol. 54
Availability: No items available.
|
|
54995.
|
|
|
54996.
|
|
|
54997.
|
Long-term outcome of patients with frequently recurrent non-muscle-invasive bladder carcinoma treated with one perioperative plus four weekly instillations of mitomycin C followed by monthly bacillus Calmette-Guérin (BCG) or alternating BCG and interferon-α2b instillations: prospective randomised FinnBladder-4 study. [electronic resource] by
- Järvinen, Riikka
- Marttila, Timo
- Kaasinen, Eero
- Rintala, Erkki
- Aaltomaa, Sirpa
- Kallio, Jukka
- Liukkonen, Tapani
- Puolakka, Veli-Matti
- Seppänen, Marjo
- Tuhkanen, Kari
- Vaarala, Markku
- Viitanen, Jouko
- Boström, Peter J
Producer: 20160608
In:
European urology vol. 68
Availability: No items available.
|
|
54998.
|
|
|
54999.
|
|
|
55000.
|
|